Connected Insulin Pumps: Accu-Chek Combo vs. Animas Ping
An FDA approval of a new diabetes device is always an exciting thing, especially for a company that’s been in the holding pen for a while, waiting to get a device to market. That was the case this summer when Roche learned it had finally secured the regulatory agency’s OK for its Accu-Chek-Combo system.
Of course, we immediately started wondering how this new pump-with-glucose-meter-connectivity stacks up to already-available Animas OneTouch Ping? Has Roche one-upped the…